logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12214004 B1

PDFFull Text
Date of Patent:
Feb. 04, 2025

Filed:

Nov. 12, 2020

Strains having effects of preventing or treating cancers

Applicant:

Genome and Company, Gyeonggi-do, KR;

Inventors:

Hansoo Park, Seoul, KR;

Shinyoung Park, Gyeonggi-do, KR;

Eun Ju Lee, Gyeonggi-do, KR;

Jae-Sung Yeon, Gyeonggi-do, KR;

Hye Hee Jeon, Gyeonggi-do, KR;

Wonduck Kim, Gyeonggi-do, KR;

Joo-Yeon Chung, Gyeonggi-do, KR;

Areum Jeong, Gyeonggi-do, KR;

Youn Kyung Houh, Gyeonggi-do, KR;

Jinyoung Sohn, Gyeonggi-do, KR;

Yun Yeon Kim, Gyeonggi-do, KR;

Sang Gyun Kim, Gyeonggi-do, KR;

Suro Lee, Gyeonggi-do, KR;

Assignee:

Genome And Company, Seongnam-Si, KR;

Attorney:

Servilla Whitney LLC

Primary Examiner:

Nelson B Moseley, Ii

Int. Cl.
CPC ...
A61K 35/745 (2015.01); A61K 31/282 (2006.01); A61K 31/337 (2006.01); A61K 31/475 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 31/7068 (2006.01); A61K 33/243 (2019.01); A61K 35/744 (2015.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C12N 1/20 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/745 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/475 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 33/243 (2019.01); A61K 35/744 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C12N 1/205 (2021.05); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01);
Abstract

The present invention relates to a novelMG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, theMG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, theMG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novelGEN3033 strain and a composition for preventing or treating cancers, comprising the same. Specifically, theGEN3033 strain of the present invention exhibits effects of directly inhibiting the proliferation of cancer cells and enhancing immunity, thereby having effects of preventing or treating cancers. In particular, the strain has an excellent anticancer effect by secreting metabolites having an anticancer effect while being established in the gut. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, theGEN3033 strain of the present invention exhibits a better anticancer effect.

Find Patent Forward Citations

Park, Hansoo. (2025). Strains having effects of preventing or treating cancers (U.S. Patent No. 12214004). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12214004

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…